Najnowsze artykuły:
NEW YORK - OS Therapies Inc. (NYSE-A: OSTX), a biotechnology firm specializing in cancer immunotherapies with a current market capitalization of $45.8 million, has requested the U.S. Food and Drug ...
Ionis Pharmaceuticals IONS announced that the FDA has granted the Breakthrough Therapy designation to its pipeline candidate, ION582, for the treatment of Angelman syndrome (AS), a rare neurological ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
A monthly antibody drug to treat sickle cell disease, developed by Novartis, has won a coveted breakthrough designation from the FDA as it heads towards its first regulatory filings. The US regulator ...
Lenmeldy Sparks Controversy as World’s Most Expensive Medicine, Debating the $4.25 Million Price Tag
The introduction of Lenmeldy has sparked debates over its justification as the world's most expensive medicine. This groundbreaking gene therapy involves using the patient's own stem cells to deliver ...
ZUG, Switzerland and BOSTON - CRISPR Therapeutics (NASDAQ:CRSP), a leader in gene-based medicine with a market capitalization of $4.3 billion, reported significant advancements in their ongoing Phase ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...